Collegium Pharmaceutical: Q4 Earnings Snapshot
Collegium Pharmaceutical: Q3 Earnings Snapshot
In this article, we look at price action strategies and uncover three companies with the potential for a breakout.
Collegium Pharmaceutical: Q2 Earnings Snapshot
Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with...
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Collegium Pharmaceutical: Q1 Earnings Snapshot
Pacira (PCRX) delivered earnings and revenue surprises of -11.67% and 2.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
COLL vs. ZTS: Which Stock Is the Better Value Option?
Pacira BioSciences (PCRX) reports mixed fourth-quarter financial results, where earnings match estimates, but revenues miss the mark.